Determinants of Detectable Anti-hepatitis B in Fertile Age Women from Indonesia

Noer Endah Pracoyo, Made Ayu Lely Suratri, Felly Philipus Senewe, Vivi Setiawaty


Hepatitis B (HBV) is still a major health problem worldwide, as evidenced by the large number of people infected with hepatitis. There are around two billion people infected with HBV, and an estimated 350 million are in chronic conditions. Hepatitis B is a ninth-order disease that causes death in mothers and their babies. The HBV infection in pregnant women is critical because of vertical or perinatal transmission. This study's purpose was to analyze data of the HBsAg and anti-HBs rertile age women, pregnant women, and postpartum mothers from National Basic Health Research Data 2007. The method is a retrospective study using secondary data from the Basic Health Research in 2007. The number of samples in the form of data on respondents of fertile age women are women aged 15 to 49 years. Data screened and matched with that examined pregnancy/have had a postpartum examination/never checked neonates/had examined their toddlers. One thousand three hundred two (1,302) respondents were eligible to be sampled in this analysis. The variables analyzed were age and anti-HB titers in women of childbearing age 15 to 49 years who were not protected against hepatitis B, as much as 74.65% of the total 1,302 people. Three hundred thirty (330) respondents had anti-HBs titers. This study concludes respondents who are not married age 15–20 years showed relationship with negative anti-Hbs antibodies.


Anti-hepatitis B titer; fertile age women; hepatitis B virus; postpartum mothers; pregnant women

Full Text:



Hwang EW, Cheung R. Global epidemiology of hepatitis B virus (HBV) infection. NAJMS. 2011;4(1):7–13.

Ugwuja EI, Ugwu NC. Seroprevalence of hepatitis B surface antigen and liver function tests among adolescents in Abakaliki, South Eastern Nigeria. IJTM. 2010;6(1):3690.

Rossi C, Shrier I, Marshall L, Cnossen S, Schwartzman K, Klein MB, et al. Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis. PLoS One. 2012;7(9):e44611.

Xin X, Wang Y, Cheng J, Zhang Y, Peng Z, Xu J, et al. Seroepidemiological survey of hepatitis B virus infection among 764,460 women of childbearing age in rural China: a cross-sectional study. J Clin Virol. 2016;81:47–52.

Pusat Data dan Informasi, Kementerian Kesehatan Republik Indonesia. Situasi dan analisis hepatitis [Internet]. Jakarta: Kementerian Kesehatan Republik Indonesia; 2014 [cited 2022 May 14]. Available from:

Badan Penelitian dan Pengembangan Kesehatan, Departemen Kesehatan Republik Indonesia. Riset kesehatan dasar (Riskesdas) 2007 [Internet]. Jakarta: Departemen Kesehatan Republik Indonesia; 2008 [cited 2022 May 24]. Available from:

Mustikah S, Hasanah D. Prevalensi infeksi hepatitis B pada ibu hamil di Malang. JKB. 2018;30(1):76–80.

Allain JP, Opare-Sem O. Screening and diagnosis of HBV in low-income and middle-income countries. Nat Rev Gastroenterol Hepatol. 2016;13(11):643–53.

Souza MT, Pinho TLRd, Santos MDC, Santos Ad, Monteiro VL, Fonsêca LMB, et al. Prevalence of hepatitis B among pregnant women assisted at the public maternity hospitals of São Luís, Maranhão, Brazil. Braz J Infect Dis. 2012;16(6):517–20.

Sinaga H, Latif I, Pangulu N. Pemeriksaan hepatitis B surface antigen (HbsAg) dan anti-Hbs pada ibu hamil sebagai skrining penularan hepatitis B. J Ris Kesehat. 2018;7(2):80–4.

Yohanes T, Zerdo Z, Chufamo N. Seroprevalence and predictors of hepatitis B virus infection among pregnant women attending routine antenatal care in Arba Minch Hospital, South Ethiopia. Hepat Res Treat. 2016;2016:9290163.

Bayo P, Ochola E, Oleo C, Mwaka AD. High prevalence of hepatitis B virus infection among pregnant women attending antenatal care: a cross-sectional study in two hospitals in northern Uganda. BMJ Open. 2014;4(11):e005889.

Chibwe E, Silago V, Kajoro E, Juma M, Mkumbo E, Minja CA, et al. Antihepatitis B surface antigen and hepatitis C antibodies among pregnant women in an urban area of Mwanza city, Tanzania. J Pregnancy. 2019;2019:7917894.

Fan L, Owusu-Edusei K Jr, Schillie SF, Murphy TP. Antiviral treatment among pregnant women with chronic hepatitis B. Infect Dis Obstet Gynecol. 2014;2014:546165.

Mukhtar NA, Toy BC, Burman BE, Yu A, Chen AH, Berman P, et al. Assessment of HBV preventive services in a medically underserved Asian and Pacific Islander population using provider and patient data. J Gen Intern Med. 2015;30(1):68–74.

Dwivedi M, Misra SP, Misra V, Pandey A, Pant S, Singh R, et al. Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian J Gastroenterol. 2011;30(2):66–71.

Teshale EH, Kamili S, Drobeniuc J, Denniston M, Bakamutamaho B, Downing R. Hepatitis B virus infection in northern Uganda: impact of pentavalent hepatitis B vaccination. Vaccine. 2015;33(46):6161–3.

Yentur Doni N, Simsek Z, Keklik Z, Gurses G, Zeyrek FY. Epidemiology of hepatitis B in the reproductive-age female farmworkers of southeastern Turkey. Hepat Mon. 2014;14(11):e22120.

Yi W, Pan CQ, Hao J, Hu Y, Liu M, Li L, et al. Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers. J Hepatol. 2014;60(3):523–9.

Kambuno NT, Bessie MF, Tangkelangi M, Djuma AW. Risk factors of intra-familial hepatitis B virus transmission among hepatitis B patients in Kupang, Indonesia. GMHC. 2019;7(2):151–6.


pISSN 2301-9123 | eISSN 2460-5441

Visitor since 19 October 2016: 

View My Stats

Free counters!

Global Medical and Health Communication is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.